Two Procedures on the same day (mod 59) | Sample set up: 10ml + Two (5) 5ml syringes
Two Procedures on the same day (mod 59) | Sample set up: 10ml + Two (5) 5ml syringes
#2 (mod 59) = Rt SI joint 20mg
Thoracic Facet (Cervical/Thoracic Medial Branch Block)
64490 – Cervical/thoracic medial branch block, first level
RT / LT if laterality applies (often not required for spine, payer-dependent)
Right Sacroiliac Joint Injection
27096-RT-59
RT = right side
-59 = distinct procedural service (different anatomic region, same day)
Key Notes
Modifier -59 is typically required to bypass bundling edits with spine procedures
Some payers may accept -XS instead of -59 (check carrier policy)
Plan Option 1
Thoracic Pain = Area of maximal pain was marked prior to injection. Thoracic facet injection completed today without complication. Monitor response and consider MBB or RFA if relief is short-lived.
Right SI Pain = Right SI joint injection completed without complication. Assess response and repeat if needed.
Plan Option 2
Thoracic Pain = Maximum pain site identified and marked. Thoracic facet injection completed today without complication. Evaluate symptom improvement and consider additional interventions if pain recurs.
Right SI Pain = Right SI joint injection completed without complication. Monitor clinical response.
Plan Option 3
Thoracic Pain = Area of greatest pain marked prior to injection. Thoracic facet injection completed today without complication. Reassess and consider further procedures if indicated.
Right SI Pain = Right SI joint injection completed without complication. Repeat or adjust treatment based on response.
Level I – Strong evidence
Multiple high-quality randomized controlled trials (RCTs) and/or consistent meta-analyses with low bias.
Level II – Moderate evidence
At least one high-quality RCT or multiple moderate-quality RCTs with consistent findings.
Level III – Limited-moderate evidence
One moderate-quality RCT and/or multiple high-quality observational studies with consistent results.
Level IV – Limited evidence
Observational studies, single-arm studies, case series, or inconsistent RCT data.
Level V – Consensus / expert opinion
Expert opinion, narrative reviews, or mechanistic rationale without controlled clinical data.
@T9 TP is T8;
@T10 TP is T9 ....
@ S1/ala is L5.
Based on the most recent systematic reviews and clinical practice guidelines, here is a comprehensive evidence mapping summary with teaching points for each modality:
Physical Therapy and Exercise
Evidence Level: I-II (High to Moderate Quality)
First-line treatment for chronic spine pain; emphasize remaining physically active and avoiding bed rest
Supporting Evidence: Multiple systematic reviews and clinical practice guidelines recommend non-pharmacologic treatments as first-line therapy. Studies demonstrate that early patient education focusing on physical activity and setting positive treatment expectations improves outcomes.
[1-2]
Chiropractic Care/Spinal Manipulation
Evidence Level: II (Moderate Quality)
Results in small improvements in pain and function comparable to, but not superior to, other recommended therapies
Supporting Evidence: Cochrane reviews and systematic reviews demonstrate that spinal manipulation provides small improvements in pain and function for chronic low back pain, with outcomes comparable to other recommended therapies.
[2]
NSAIDs
Evidence Level: I (High Quality)
Best initial pharmacologic treatment; more effective than placebo for pain and disability
Supporting Evidence: Cochrane reviews demonstrate NSAIDs are more effective than placebo with respect to pain and disability.
[2]
Epidural Steroid Injections (ESI)
For Radicular Pain/Disc Herniation:
Evidence Level: II (Moderate Quality for short-term benefit)
Moderately effective for short-term symptom relief in radicular pain; not effective for long-term relief
Supporting Evidence:
For lumbar radicular pain from disc pathology, Cochrane review found evidence for only small short-term benefits compared to placebo
[1]
Strong recommendation AGAINST for chronic radicular spine pain (≥3 months) per 2025 BMJ guidelines
[3]
Network meta-analysis shows epidural injection of local anesthetic and steroids probably provides little to no difference in pain relief (WMD -0.49, 95% CI -1.54 to 0.55; moderate certainty)
[4]
For neck pain related to disc herniation, moderate evidence supports ESI for long-term improvements
[1]
For Axial/Non-Radicular Pain:
Evidence Level: IV-V (Low to Very Low Quality)
Radiofrequency Ablation (RFA) - Facet Joint
Evidence Level: V (Very Low Quality)
Facet Joint Injections (Steroid/Local Anesthetic)
Evidence Level: III-IV (Low to Very Low Quality)
Sacroiliac Joint Injections (Steroid)
Evidence Level: IV (Limited Quality)
Spinal Cord Stimulation (SCS)
Evidence Level: II (Moderate Quality for specific indication)
Moderately effective for failed back surgery syndrome with persistent radiculopathy; device-related complications are common
Supporting Evidence: Fair evidence that SCS is moderately effective for failed back surgery syndrome with persistent radiculopathy, though device-related complications are common. FDA-approved for chronic pain since 1967.
[1][5]
Peripheral Nerve Stimulation (PNS)
Emerging therapy
Platelet-Rich Plasma (PRP) - Intradiscal
Evidence Level: III (Fair Quality)
Moderate consensus-based recommendation
Not FDA-approved; considered off-label use
Platelet-Rich Plasma (PRP) - Epidural
Evidence Level: III (Fair Quality)
Moderate consensus-based recommendation; emerging evidence suggests potential benefit
Platelet-Rich Plasma (PRP) - Facet Joint
Evidence Level: IV (Limited Quality)
Teaching Point: Moderate consensus-based recommendation; limited evidence base
Supporting Evidence:
2025 ASIPP guidelines: Level IV evidence with moderate consensus-based recommendation
[6]
2018 systematic review: Level 4 evidence without meta-analysis
[7]
Well-designed case-control or cohort studies demonstrate efficacy, but currently level IV evidence
[10-11]
Platelet-Rich Plasma (PRP) - Sacroiliac Joint
Evidence Level: IV (Limited Quality)
Teaching Point: Low consensus-based recommendation; very limited evidence
Supporting Evidence:
2025 ASIPP guidelines: Level IV evidence with low consensus-based recommendation
[6]
2018 systematic review: Level 4 evidence without meta-analysis
[7]
PRP compared favorably to steroid injections in sacroiliac joint for chronic low back pain
[11]
Mesenchymal Stem Cells (MSCs) - Intradiscal
Evidence Level: III (Fair Quality)
Moderate consensus-based recommendation; promising but requires high-quality RCTs; not FDA-approved
Not FDA-approved for pain or musculoskeletal conditions; only approved for hematologic malignancies
[6]
Bone Marrow Aspirate Concentrate (BMAC) - Intradiscal
Evidence Level: III (Fair Quality)
Surgery (Discectomy, Fusion, Decompression)
Evidence Level: I-II (High to Moderate Quality for specific indications)
Reserved for patients with specific indications (progressive neurological deficit, cauda equina syndrome, failure of conservative therapy with anatomic correlation)
The 2025 ASIPP guidelines acknowledge the "emerging status of biologic therapies and limited quality of existing studies".
First-Line Approach:
Non-pharmacologic treatments remain first-line for chronic low back pain, with emphasis on remaining physically active, patient education, exercise, physical therapy, and behavioral counseling.
Evidence Quality Gap:
There is a striking disconnect between clinical practice patterns and evidence quality; many commonly performed interventional procedures lack high-quality evidence supporting their use, however, an increasing number of patients benefit from these therapies and seek them as an alternative to opioid medicines, other types of medicines and to avoid the risks of surgery and anesthesia, if possible.
Chronic Pain: An Update on Burden, Best Practices, and New Advances.
Lancet. 2021. Cohen SP, Vase L, Hooten WM.
2.
Chronic Low Back Pain in Adults: Evaluation and Management.
American Family Physician. 2024. Maharty DC, Hines SC, Brown RB.
3.
BMJ. 2025. Busse JW, Genevay S, Agarwal A, et al.New
4.
BMJ. 2025. Wang X, Martin G, Sadeghirad B, et al.New
5.
Spine. 2009. Chou R, Atlas SJ, Stanos SP, Rosenquist RW.
6.
Pain Physician. 2025. Manchikanti L, Navani R, Navani A, et al.New
7.
Pain Physician. 2018. Sanapati J, Manchikanti L, Atluri S, et al.
8.
Platelet-Rich Plasma Treatment for the Lumbar Spine: A Review and Discussion of Existing Gaps.
Pain Physician. 2024. Yum JI, De Luigi AJ, Umphrey GL, Ganter BK, Yoo M.
9.
Advances in Platelet-Rich Plasma Treatment for Spinal Diseases: A Systematic Review.
International Journal of Molecular Sciences. 2023. Kawabata S, Akeda K, Yamada J, et al.
10.
Platelet-Rich Plasma Injections: Pharmacological and Clinical Considerations in Pain Management.
Current Pain and Headache Reports. 2022. Grossen AA, Lee BJ, Shi HH, et al.
11.
Regenerative Medicine: Pharmacological Considerations and Clinical Role in Pain Management.
Current Pain and Headache Reports. 2022. Kaye AD, Edinoff AN, Rosen YE, et al.
12.
Diagnosis and Treatment of Low Back Pain (LBP) (2022).
Department of Veterans Affairs. 2022. Maj Danielle Anderson DPT DSc OCS FAAOMPT, Thiru M. Annaswamy MD MA, LTC Adam J. Bevevino MD, et alGuideline
s/p cervical facet injection (CFI) – continue to monitor for improvement and response to treatment; follow up with the surgery team as instructed.
s/p cervical epidural steroid injection (CESI) – continue to monitor for improvement and response to treatment; follow up with the surgery team as instructed.
s/p lumbar facet injection (LFI) – continue to monitor for improvement and response to treatment; follow up with the surgery team as instructed.
s/p lumbar epidural steroid injection (LESI) – continue to monitor for improvement and response to treatment; follow up with the surgery team as instructed.
s/p trigger point injection (TPI) – continue to monitor for improvement and response to treatment; follow up with the surgery team as instructed.
s/p sacroiliac joint injection (SI joint) – continue to monitor for improvement and response to treatment; follow up with the surgery team as instructed.
s/p occipital nerve block – continue to monitor for improvement and response to treatment; follow up with the surgery team as instructed.
s/p cervical radiofrequency ablation (cervical RFA) – continue to monitor for improvement and response to treatment; follow up with the surgery team as instructed.
s/p lumbar radiofrequency ablation (lumbar RFA) – continue to monitor for improvement and response to treatment; follow up with the surgery team as instructed.
===
s/p cervical facet injection (CFI) – continue to monitor for improvement and response to treatment; follow up as instructed.
s/p cervical epidural steroid injection (CESI) – continue to monitor for improvement and response to treatment; follow up as instructed.
s/p lumbar facet injection (LFI) – continue to monitor for improvement and response to treatment; follow up as instructed.
s/p lumbar epidural steroid injection (LESI) – continue to monitor for improvement and response to treatment; follow up as instructed.
s/p trigger point injection (TPI) – continue to monitor for improvement and response to treatment; follow up as instructed.
s/p sacroiliac joint injection (SI joint) – continue to monitor for improvement and response to treatment; follow up as instructed.
s/p occipital nerve block – continue to monitor for improvement and response to treatment; follow up as instructed.
s/p cervical radiofrequency ablation (cervical RFA) – continue to monitor for improvement and response to treatment; follow up as instructed.
s/p lumbar radiofrequency ablation (lumbar RFA) – continue to monitor for improvement and response to treatment; follow up as instructed.